Hepatocellular Carcinoma Morpheus Neo Hcc clinical trials

Explore recruiting hepatocellular carcinoma morpheus neo hcc clinical trials.

Also recruiting in Europe

Hepatocellular Carcinoma Morpheus Neo Hcc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE IB/II, OPEN-LABEL, MULTICENTER, RANDOMIZED PLATFORM STUDY EVALUATING THE EFFICACY AND SAFETY OF NEOADJUVANT IMMUNOTHERAPY COMBINATIONS IN PATIENTS WITH SURGICALLY RESECTABLE HEPATOCEULLULAR CARCINOMA (MORPHEUS-NEO HCC)

Austria, Spain, Germany, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Hepatocellular Carcinoma Morpheus Neo Hcc trials by city

Hepatocellular Carcinoma Morpheus Neo Hcc in Toronto Hepatocellular Carcinoma Morpheus Neo Hcc in Vancouver Hepatocellular Carcinoma Morpheus Neo Hcc in Montreal Hepatocellular Carcinoma Morpheus Neo Hcc in Calgary Hepatocellular Carcinoma Morpheus Neo Hcc in Edmonton Hepatocellular Carcinoma Morpheus Neo Hcc in Ottawa Hepatocellular Carcinoma Morpheus Neo Hcc in Winnipeg Hepatocellular Carcinoma Morpheus Neo Hcc in Quebec City Hepatocellular Carcinoma Morpheus Neo Hcc in Hamilton Hepatocellular Carcinoma Morpheus Neo Hcc in Kitchener Hepatocellular Carcinoma Morpheus Neo Hcc in London Hepatocellular Carcinoma Morpheus Neo Hcc in Halifax Hepatocellular Carcinoma Morpheus Neo Hcc in New York Hepatocellular Carcinoma Morpheus Neo Hcc in Los Angeles Hepatocellular Carcinoma Morpheus Neo Hcc in Chicago Hepatocellular Carcinoma Morpheus Neo Hcc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease